DOTS

ERED

Environmental Residue-Effects Database

US Army Corps of Engineers ERDC Dredging Operations Technical Support

USACE


Field Name Description
% Effect   The magnitude of the effect (e.g., % mortality; change in weight; change in length; percent hatch; etc.). 
Analyte   The chemical substance used to create the exposure.  
CAS   CAS registry number is a unique numerical identifier assigned by Chemical Abstract Service (CAS) to a chemical substance.  
COLL  Where the animal was obtained: C (cultured-reared in laboratory); W (collected from wild); N/I (No Information); N/R (Not Reported). 
Comments  Commonly supports the effects data. 
Common name  Common name of the test animal. 
Control   The control response for the observed effect (e.g., survival, growth, reproduction; etc.). 
Dose  The frequency with which the contaminant was applied during the test. 
Duration   The duration of the exposure period: hr (hours); d (days) wk (weeks), mo (months), yr (years). 
Effect   The type of toxicological effect observed in the test animal (e.g., survival, growth, reproduction). 
ERED ID  Unique identification number autogenerated by database. 
ExpConc  The exposure concentration and units. 
Fraction   The test animal tissue used to determine tissue residue (e.g., whole body, soft tissue, liver, etc.). 
Genus Species   Scientific name of the test animal. 
Media  Type of water used to test animal: FW (freshwater); SW (saltwater) 
Mix   Whether the analyte was tested as part of a mixture of analytes or individually: yes (part of mixture), no (single), or N/I (No information). 
Risk   Summary of the risk (e.g., ED, NOED, LOED) an analyte might pose to the test animal. Previously, many risk numbers were assigned to results. Going forward ERED will not report a risk number unless it is reported in the study.  
Route   The route by which the analyte was intended to enter the body: aquatic; diet; injection. 
Signif   Whether the effect was significantly different, usually compared to the control for laboratory studies: Yes (significant); No (not significant). 
Source  Reference from which data was obtained. 
Spiked  Whether the analyte was spiked into the route (aquatic, diet, sediment, injection): yes (analyte spiked), no (analyte not spiked) 
ST  Study type: L (Lab); F (Field); L/F (Lab/Field); Meso (Mesocosm); Micro (Microcosm); N/I (No Information). 
Stage   Life stage of the test animal (e.g., egg, larval, juvenile, adult). 
Tissue ww (mg/kg)   Tissue residue of analyte in the test animal tissue (mg/kg wet weight). 
Trend   The trend of the effect, usually compared to the control for laboratory studies: INC (increase); DEC (decrease), NEF (No effect). 

Source: Geffard et al. 2003. Assessment of the bioavailability and to.... Mar Pollut Bull 46:481-490..

Genus Species ERED ID ST Common Stage COLL Analyte CAS MX SPK H2O Route CONC Dose DUR Residue
mg/kg ww
Fraction Effect Trend Signif % Effect Control Risk Comments Source
Crassostrea gigas 18605 L oyster, Pacific embryo N/R Copper 7440-50-8 Y N SW sediment N/I 1x 1 d 1.72 whole body cellular N/I N 944 ug/g 615 ug/g N/R MT induction; Cu correlated highly; PAHs, Zn, Cd also present Geffard et al. 2003. Assessment of the bioavailability and to.... Mar Pollut Bull 46:481-490.
Crassostrea gigas 18606 L oyster, Pacific embryo N/R Copper 7440-50-8 Y N SW sediment N/I 1x 1 d 1.92 whole body cellular INC Y 1162 ug/g 615 ug/g N/R MT induction; Cu correlated highly; PAHs, Zn, Cd also present Geffard et al. 2003. Assessment of the bioavailability and to.... Mar Pollut Bull 46:481-490.
Crassostrea gigas 18607 L oyster, Pacific embryo N/R Copper 7440-50-8 Y N SW sediment N/I 1x 1 d 2.58 whole body cellular INC Y 1149 ug/g 615 ug/g N/R MT induction; Cu correlated highly; PAHs, Zn, Cd also present Geffard et al. 2003. Assessment of the bioavailability and to.... Mar Pollut Bull 46:481-490.
Crassostrea gigas 18608 L oyster, Pacific embryo N/R Copper 7440-50-8 Y N SW sediment N/I 1x 1 d 1.39 whole body cellular N/I N 749 ug/g 607 ug/g N/R MT induction; Cu correlated highly; PAHs, Zn, Cd also present Geffard et al. 2003. Assessment of the bioavailability and to.... Mar Pollut Bull 46:481-490.
Crassostrea gigas 18609 L oyster, Pacific embryo N/R Copper 7440-50-8 Y N SW sediment N/I 1x 1 d 1.49 whole body cellular N/I N 722 ug/g 607 ug/g N/R MT induction; Cu correlated highly; PAHs, Zn, Cd also present Geffard et al. 2003. Assessment of the bioavailability and to.... Mar Pollut Bull 46:481-490.
Crassostrea gigas 18610 L oyster, Pacific embryo N/R Copper 7440-50-8 Y N SW sediment N/I 1x 1 d 1.76 whole body cellular N/I N 820 ug/g 607 ug/g N/R MT induction; Cu correlated highly; PAHs, Zn, Cd also present Geffard et al. 2003. Assessment of the bioavailability and to.... Mar Pollut Bull 46:481-490.
Crassostrea gigas 18611 L oyster, Pacific embryo N/R Copper 7440-50-8 Y N SW sediment N/I 1x 1 d 2.29 whole body cellular N/I N 952 ug/g 607 ug/g N/R MT induction; Cu correlated highly; PAHs, Zn, Cd also present Geffard et al. 2003. Assessment of the bioavailability and to.... Mar Pollut Bull 46:481-490.
Crassostrea gigas 18596 L oyster, Pacific embryo N/R PAHs 130498-29-2 Y N SW sediment N/I 1x 1 d 0.05 whole body development N/I N 8.9% 9.5% N/R % abnormal; Cu, Zn, Cd in sediment Geffard et al. 2003. Assessment of the bioavailability and to.... Mar Pollut Bull 46:481-490.
Crassostrea gigas 18597 L oyster, Pacific embryo N/R PAHs 130498-29-2 Y N SW sediment N/I 1x 1 d 0.06 whole body development N/I N 9.8% 9.5% N/R % abnormal; Cu, Zn, Cd in sediment Geffard et al. 2003. Assessment of the bioavailability and to.... Mar Pollut Bull 46:481-490.
Crassostrea gigas 18598 L oyster, Pacific embryo N/R PAHs 130498-29-2 Y N SW sediment N/I 1x 1 d 0.06 whole body development N/I N 12.1% 9.5% N/R % abnormal; Cu, Zn, Cd in sediment Geffard et al. 2003. Assessment of the bioavailability and to.... Mar Pollut Bull 46:481-490.
Crassostrea gigas 18600 L oyster, Pacific embryo N/R PAHs 130498-29-2 Y N SW sediment N/I 1x 1 d 0.04 whole body development N/I N 8.6% 8.2% N/R % abnormal; Cu, Zn, Cd in sediment Geffard et al. 2003. Assessment of the bioavailability and to.... Mar Pollut Bull 46:481-490.
Crassostrea gigas 18601 L oyster, Pacific embryo N/R PAHs 130498-29-2 Y N SW sediment N/I 1x 1 d 0.05 whole body development N/I N 7.2% 8.2% N/R % abnormal; Cu, Zn, Cd in sediment Geffard et al. 2003. Assessment of the bioavailability and to.... Mar Pollut Bull 46:481-490.
Crassostrea gigas 18602 L oyster, Pacific embryo N/R PAHs 130498-29-2 Y N SW sediment N/I 1x 1 d 0.06 whole body development N/I N 7.4% 8.2% N/R % abnormal; Cu, Zn, Cd in sediment Geffard et al. 2003. Assessment of the bioavailability and to.... Mar Pollut Bull 46:481-490.
Crassostrea gigas 18603 L oyster, Pacific embryo N/R PAHs 130498-29-2 Y N SW sediment N/I 1x 1 d 0.07 whole body development INC Y 16.8% 8.2% N/R % abnormal; Cu, Zn, Cd in sediment Geffard et al. 2003. Assessment of the bioavailability and to.... Mar Pollut Bull 46:481-490.